Anjan Dasgupta

Prof. Dr. Anjan Dasgupta

Project Consultancy in the parent Department after retiring as Professor
+1
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2013 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
SSSounik Sarkar
Sounik Sarkar
MAMohammed Aftab Alam
Mohammed Aftab Alam
JSJyoti Shaw
Jyoti Shaw
ADAnjan Dasgupta
Anjan Dasgupta

13 September 2017 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
JSJyoti Shaw
Jyoti Shaw
ACAyan Chakraborty
Ayan Chakraborty
ANArijit Nag
Arijit Nag
ACArnab Chattopadyay
Arnab Chattopadyay
ADAnjan Dasgupta
Anjan Dasgupta
MBMaitreyee Bhattacharyya
Maitreyee Bhattacharyya

31 August 2012 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
HPHirak K Patra
Hirak K Patra
ADAnjan Dasgupta
Anjan Dasgupta

1 January 2011 in Cancer Nanotechnology
Verified
Journal Article
Open access
PDF file
HPHirak K Patra
Hirak K Patra
ADAnjan Dasgupta
Anjan Dasgupta
SSSounik Sarkar
Sounik Sarkar
IBIndranil Biswas
Indranil Biswas
ACArnab Chattopadhyay
Arnab Chattopadhyay
The conventional chemotherapeutic agents used in the treatment of human malignancies are directed nonspecifically against both malignant and nonmalignant cells, often limiting their efficacy with having serious side effects. Recent development of drug delivery vehicles has opened up the possibility of targeted drug delivery systems with the potential of achieving maximum efficacy with minimal toxicity. The possibility of using a nanomaterial as a combinational drug component is intuitively evident as it would compensate the toxicity level by enhancing drug delivery efficiency. Additionally, cell-specific cytotoxicity (reported earlier by our group) of the nanovehicle itself may potentiate a more effective targeted cell killing. In this paper, we explore the possibility of using gold nanoparticles playing the dual role of an anticancer agent and a carrier of a chemotherapeutic drug. This is demonstrated using vincristine sulfate (VS), salt of an alkaloid often used in the treatment of multiple myeloma (MM), and U266 as a test MM cell line. The drug VS shows the expected G2-M-phase arrest of cells. Notably, bare gold nanoparticle shows arrest of the S phase cells that may be particularly important in case of slow-growing malignancies like MM where most of the cells remain in G1 phase of the cell cycle. The VS conjugated gold retains the activity of both gold nanoparticle and VS leading to a synergistic rise of the apoptotic cell population.

25 July 2013 in Nanoscale
Verified
Journal Article
Closed access
PDF file
TBTamoghna Bhattacharyya
Tamoghna Bhattacharyya
SSSarbani Samaddar
Sarbani Samaddar
ADAnjan Dasgupta
Anjan Dasgupta
Lipid functionalized single walled carbon nanotube-based self assembly forms a super-micellar structure. This assemblage has been exploited to trap glucose oxidase in a molecular cargo for glucose sensing. The advantage of such a molecular trap is that all components of this unique structure (both the trapping shell and the entrapped enzyme) are reusable and rechargeable. The unique feature of this sensing method lies in the solid state functionalization of single walled carbon nanotubes that facilitates liquid state immobilization of the enzyme. The method can be used for soft-immobilization (a new paradigm in enzyme immobilization) of enzymes with better thermostability that is imparted by the strong hydrophobic environment provided through encapsulation by the nanotubes.

4 October 2011 in Discover Nano
Verified
Journal Article
Open access
PDF file
SGSarmishtha Ghoshal
Sarmishtha Ghoshal
AAAbul Am Ansar
Abul Am Ansar
SRSufi O Raja
Sufi O Raja
AJArpita Jana
Arpita Jana
NBNil R Bandyopadhyay
Nil R Bandyopadhyay
MRMallar Ray
Mallar Ray
A uniformly distributed array of micro test tubes and microbeakers is formed on a p-type silicon substrate with tunable cross-section and distance of separation by anodic etching of the silicon wafer in N, N-dimethylformamide and hydrofluoric acid, which essentially leads to the formation of macroporous silicon templates. A reasonable control over the dimensions of the structures could be achieved by tailoring the formation parameters, primarily the wafer resistivity. For a micro test tube, the cross-section (i.e., the pore size) as well as the distance of separation between two adjacent test tubes (i.e., inter-pore distance) is typically approximately 1 μm, whereas, for a microbeaker the pore size exceeds 1.5 μm and the inter-pore distance could be less than 100 nm. We successfully synthesized superparamagnetic iron oxide nanoparticles (SPIONs), with average particle size approximately 20 nm and attached them on the porous silicon chip surface as well as on the pore walls. Such SPION-coated arrays of micro test tubes and microbeakers are potential candidates for biosensors because of the biocompatibility of both silicon and SPIONs. As acquisition of data via microarray is an essential attribute of high throughput bio-sensing, the proposed nanostructured array may be a promising step in this direction.